Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

People with alopecia have a higher risk of thyroid cancer.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Proper education can prevent traction alopecia in women of color.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Folliculitis decalvans is a rare skin disease causing hair loss and requires personalized treatment.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

The exam tested knowledge on various skin-related topics for CME credit.

Thymoma in cats can cause hair loss without inflammation.

Infants with scalp injuries developed a skin condition that improved with steroid creams.

A rare scalp condition was successfully treated with specific medications after 9 months.

Scalp condition healed with prednisone and tacrolimus.

Oral zinc and topical steroids can effectively treat chronic scalp pustules and hair loss in elderly patients.

A woman developed thick gums from everolimus treatment after a kidney transplant.

A rare scalp condition mainly in older women can be treated with various alternatives to steroids, which may have fewer side effects.

Topical tacrolimus effectively treated scalp lesions, reversed skin atrophy, and promoted hair growth.

Using minoxidil can cause severe skin reactions in some people.

An infant with a zinc deficiency skin disorder improved with zinc treatment.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

A woman developed a scalp condition from using minoxidil, which improved with a different treatment but left scarring.

Two elderly men developed scalp inflammation after using a gel for skin lesions, which healed with treatment except for some permanent hair loss.